European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay

Author:

Braun Patrick1,Delgado Rafael2,Drago Monica3,Fanti Diana3,Fleury Hervé4,Gismondo Maria Rita5,Hofmann Jörg6,Izopet Jacques7,Kühn Sebastian6,Lombardi Alessandra5,Marcos Maria Angeles8,Sauné Karine7,O'Shea Siobhan9,Pérez-Rivilla Alfredo2,Ramble John9,Trimoulet Pascale4,Vila Jordi8ORCID,Whittaker Duncan10,Artus Alain11,Rhodes Daniel W.11

Affiliation:

1. Laboratory Dr. Knechten, Medical Center for HIV and Hepatitis, Aachen, Germany

2. Microbiology Department, Hospital Universitario 12 de Octubre and Insituto de Investigation, Hospital 12 de Octubre (i+12), Madrid, Spain

3. Clinical Chemistry and Microbiology laboratories, Niguarda Ca' Granda Hospital, Milan, Italy

4. Virology Department, Hôpital Pellegrin, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France

5. Clinical Microbiology, Virology and Bioemergence Diagnosis, L. Sacco University Hospital, Milan, Italy

6. Virology Department, Labor Berlin, Charité Vivantes GmbH, Berlin, Germany

7. Department of Virology, Federative Institute of Biology, Centre Hospitalier Universitaire Toulouse, Toulouse, France

8. Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Centre for International Health Research Barcelona (CRESIB), Barcelona, Spain

9. Viapath Analytics, Infection Sciences, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

10. Laboratory Medicine Building, Northern General Hospital, Sheffield, United Kingdom

11. Beckman Coulter, Immunotech, Marseille, France

Abstract

ABSTRACT The analytical performance of the Veris HCV Assay for use on the new and fully automated Beckman Coulter DxN Veris Molecular Diagnostics System (DxN Veris System) was evaluated at 10 European virology laboratories. Precision, analytical sensitivity, specificity, and performance with negative samples, linearity, and performance with hepatitis C virus (HCV) genotypes were evaluated. Precision for all sites showed a standard deviation (SD) of 0.22 log 10 IU/ml or lower for each level tested. Analytical sensitivity determined by probit analysis was between 6.2 and 9.0 IU/ml. Specificity on 94 unique patient samples was 100%, and performance with 1,089 negative samples demonstrated 100% not-detected results. Linearity using patient samples was shown from 1.34 to 6.94 log 10 IU/ml. The assay demonstrated linearity upon dilution with all HCV genotypes. The Veris HCV Assay demonstrated an analytical performance comparable to that of currently marketed HCV assays when tested across multiple European sites.

Funder

Beckman Coulter, Inc.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference21 articles.

1. Diagnosis, management, and treatment of hepatitis C: An update

2. Global challenges in liver disease

3. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

4. Chronic Hepatitis C Infection

5. Ray SC Thomas DL . Hepatitis C, p 2157–2186. InMandellGLBennettJEDolinR (ed), Mandell, Douglas, and Bennett's principles and practice of infectious disease, 7th ed. Churchill Livingston, Philadelphia, PA.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3